SS&H Financial Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
SS&H Financial Advisors's BMY Position: Q2 2026 in Review
SS&H Financial Advisors opened a new position in Bristol-Myers Squibb (BMY) in Q2 2026: 72,300 shares worth $4.17M. The stake represents 1.07% of the portfolio and ranks #24 among its holdings. This is a return to the name: SS&H Financial Advisors previously reported a position in BMY as recently as Q4 2025.
SS&H Financial Advisors first reported a position in BMY in Q1 2022 and has held it in 16 quarters since. 2,517 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- SS&H Financial Advisors held 72,300 shares of Bristol-Myers Squibb worth $4.17M as of Q2 2026.
- Bristol-Myers Squibb was a new SS&H Financial Advisors position in Q2 2026.
- Bristol-Myers Squibb made up 1.07% of SS&H Financial Advisors's portfolio in Q2 2026, its #24 holding.
- SS&H Financial Advisors first reported a position in Bristol-Myers Squibb in Q1 2022 and has held it in 16 quarters since.
- 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on SS&H Financial Advisors's 13F filing for Q2 2026, filed 4 Aug 2026.